Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2013

Open Access 01-12-2013 | Research article

The role of inflammation in HPV infection of the Oesophagus

Authors: Georgia Schäfer, Siti Kabanda, Beverly van Rooyen, Martina Bergant Marušič, Lawrence Banks, M Iqbal Parker

Published in: BMC Cancer | Issue 1/2013

Login to get access

Abstract

Background

Several human cancers are known to be associated with inflammation and/or viral infections. However, the influence of tumour-related inflammation on viral uptake is largely unknown. In this study we used oesophageal squamous cell carcinoma (OSCC) as a model system since this type of cancer is associated with chronic irritation, inflammation and viral infections. Although still debated, the most important viral infection seems to be with Human Papillomavirus (HPV). The present study focused on a possible correlation between inflammation, OSCC development and the influence of HPV infection.

Methods

A total of 114 OSCC biopsies and corresponding normal tissue were collected at Groote Schuur Hospital and Tygerberg Hospital, Cape Town (South Africa), that were subjected to RNA and DNA isolation. RNA samples were analysed by quantitative Light Cycler RT-PCR for the expression of selected genes involved in inflammation and infection, while conventional PCR was performed on the DNA samples to assess the presence of integrated viral DNA. Further, an in vitro infection assay using HPV pseudovirions was established to study the influence of inflammation on viral infectivity using selected cell lines.

Results

HPV DNA was found in about 9% of OSCC patients, comprising predominantly the oncogenic type HPV18. The inflammatory markers IL6 and IL8 as well as the potential HPV receptor ITGA6 were significantly elevated while IL12A was downregulated in the tumour tissues. However, none of these genes were expressed in a virus-dependent manner. When inflammation was mimicked with various inflammatory stimulants such as benzo-α-pyrene, lipopolysaccharide and peptidoglycan in oesophageal epithelial cell lines in vitro, HPV18 pseudovirion uptake was enhanced only in the benzo-α-pyrene treated cells. Interestingly, HPV pseudovirion infectivity was independent of the presence of the ITGA6 receptor on the surface of the tested cells.

Conclusion

This study showed that although the carcinogen benzo-α-pyrene facilitated HPV pseudovirion uptake into cells in culture, HPV infectivity was independent of inflammation and seems to play only a minor role in oesophageal cancer.
Appendix
Available only for authorised users
Literature
1.
Zur Hausen H: Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. Journal of the National Cancer Institute. 2000, 92 (9): 690-698. 10.1093/jnci/92.9.690.CrossRefPubMed
2.
Kuper H, Adami HO, Trichopoulos D: Infections as a major preventable cause of human cancer. J Intern Med. 2000, 248 (3): 171-183. 10.1046/j.1365-2796.2000.00742.x.CrossRefPubMed
3.
Mantovani A, Allavena P, Sica A, Balkwill F: Cancer-related inflammation. Nature. 2008, 454 (7203): 436-444. 10.1038/nature07205.CrossRefPubMed
4.
5.
Lam AK: Molecular biology of esophageal squamous cell carcinoma. Crit Rev Oncol Hematol. 2000, 33 (2): 71-90. 10.1016/S1040-8428(99)00054-2.CrossRefPubMed
6.
Chalasani N, Wo JM, Waring JP: Racial differences in the histology, location, and risk factors of esophageal cancer. J Clin Gastroenterol. 1998, 26 (1): 11-13. 10.1097/00004836-199801000-00004.CrossRefPubMed
7.
Lagergren J, Bergstrom R, Lindgren A, Nyren O: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999, 340 (11): 825-831. 10.1056/NEJM199903183401101.CrossRefPubMed
8.
Vaughan TL, Davis S, Kristal A, Thomas DB: Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 1995, 4 (2): 85-92.PubMed
9.
Xu XC: Risk factors and gene expression in esophageal cancer. Methods in molecular biology (Clifton, NJ. 2009, 471: 335-360. 10.1007/978-1-59745-416-2_17.CrossRef
10.
Laborde RR, Novakova V, Olsen KD, Kasperbauer JL, Moore EJ, Smith DI: Expression profiles of viral responsive genes in oral and oropharyngeal cancers. Eur J Cancer. 2010, 46 (6): 1153-1158. 10.1016/j.ejca.2010.01.026.CrossRefPubMed
11.
Sur M, Cooper K: The role of the human papilloma virus in esophageal cancer. Pathology. 1998, 30 (4): 348-354. 10.1080/00313029800169616.CrossRefPubMed
12.
Williamson AL, Jaskiesicz K, Gunning A: The detection of human papillomavirus in oesophageal lesions. Anticancer Res. 1991, 11 (1): 263-265.PubMed
13.
Awerkiew S, Bollschweiler E, Metzger R, Schneider PM, Holscher AH, Pfister H: Esophageal cancer in Germany is associated with Epstein-Barr-virus but not with papillomaviruses. Medical microbiology and immunology. 2003, 192 (3): 137-140. 10.1007/s00430-002-0128-z.CrossRefPubMed
14.
Matsha T, Erasmus R, Kafuko AB, Mugwanya D, Stepien A, Parker MI: Human papillomavirus associated with oesophageal cancer. J Clin Pathol. 2002, 55 (8): 587-590. 10.1136/jcp.55.8.587.CrossRefPubMedPubMedCentral
15.
Awerkiew S, Zur Hausen A, Baldus SE, Holscher AH, Sidorenko SI, Kutsev SI, Pfister HJ: Presence of Epstein-Barr virus in esophageal cancer is restricted to tumor infiltrating lymphocytes. Medical microbiology and immunology. 2005, 194 (4): 187-191. 10.1007/s00430-004-0233-2.CrossRefPubMed
16.
Seto E, Yang L, Middeldorp J, Sheen TS, Chen JY, Fukayama M, Eizuru Y, Ooka T, Takada K: Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression. Journal of medical virology. 2005, 76 (1): 82-88. 10.1002/jmv.20327.CrossRefPubMed
17.
Dreilich M, Bergqvist M, Moberg M, Brattstrom D, Gustavsson I, Bergstrom S, Wanders A, Hesselius P, Wagenius G, Gyllensten U: High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study. BMC cancer. 2006, 6: 94-10.1186/1471-2407-6-94.CrossRefPubMedPubMedCentral
18.
Si HX, Tsao SW, Poon CS, Wang LD, Wong YC, Cheung AL: Viral load of HPV in esophageal squamous cell carcinoma. Int J Cancer. 2003, 103 (4): 496-500. 10.1002/ijc.10865.CrossRefPubMed
19.
Castillo A, Aguayo F, Koriyama C, Torres M, Carrascal E, Corvalan A, Roblero JP, Naquira C, Palma M, Backhouse C: Human papillomavirus in esophageal squamous cell carcinoma in Colombia and Chile. World J Gastroenterol. 2006, 12 (38): 6188-6192.CrossRefPubMedPubMedCentral
20.
Shuyama K, Castillo A, Aguayo F, Sun Q, Khan N, Koriyama C, Akiba S: Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China. British journal of cancer. 2007, 96 (10): 1554-1559. 10.1038/sj.bjc.6603765.CrossRefPubMedPubMedCentral
21.
22.
Tezal M: Interaction between Chronic Inflammation and Oral HPV Infection in the Etiology of Head and Neck Cancers. International journal of otolaryngology. 2012, 2012: 575242-CrossRefPubMedPubMedCentral
23.
Cuschieri K, Wentzensen N: Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia. Cancer Epidemiol Biomarkers Prev. 2008, 17 (10): 2536-2545. 10.1158/1055-9965.EPI-08-0306.CrossRefPubMedPubMedCentral
24.
25.
Lin WW, Karin M: A cytokine-mediated link between innate immunity, inflammation, and cancer. The Journal of clinical investigation. 2007, 117 (5): 1175-1183. 10.1172/JCI31537.CrossRefPubMedPubMedCentral
26.
Alam S, Conway MJ, Chen HS, Meyers C: The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis. J Virol. 2008, 82 (2): 1053-1058. 10.1128/JVI.01813-07.CrossRefPubMed
27.
Bowser BS, Alam S, Meyers C: Treatment of a human papillomavirus type 31b-positive cell line with benzo[a]pyrene increases viral titer through activation of the Erk1/2 signaling pathway. J Virol. 2011, 85 (10): 4982-4992. 10.1128/JVI.00133-11.CrossRefPubMedPubMedCentral
28.
Podechard N, Lecureur V, Le Ferrec E, Guenon I, Sparfel L, Gilot D, Gordon JR, Lagente V, Fardel O: Interleukin-8 induction by the environmental contaminant benzo(a)pyrene is aryl hydrocarbon receptor-dependent and leads to lung inflammation. Toxicology letters. 2008, 177 (2): 130-137. 10.1016/j.toxlet.2008.01.006.CrossRefPubMed
29.
Chen J, Yan Y, Li J, Ma Q, Stoner GD, Ye J, Huang C: Differential requirement of signal pathways for benzo[a]pyrene (B[a]P)-induced nitric oxide synthase (iNOS) in rat esophageal epithelial cells. Carcinogenesis. 2005, 26 (6): 1035-1043. 10.1093/carcin/bgi052.CrossRefPubMed
30.
Xie XH, Law HK, Wang LJ, Li X, Yang XQ, Liu EM: Lipopolysaccharide induces IL-6 production in respiratory syncytial virus-infected airway epithelial cells through the toll-like receptor 4 signaling pathway. Pediatric research. 2009, 65 (2): 156-162. 10.1203/PDR.0b013e318191f5c6.CrossRefPubMed
31.
Bocker U, Yezerskyy O, Feick P, Manigold T, Panja A, Kalina U, Herweck F, Rossol S, Singer MV: Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression. International journal of colorectal disease. 2003, 18 (1): 25-32. 10.1007/s00384-002-0415-6.CrossRefPubMed
32.
Ajuwon KM, Banz W, Winters TA: Stimulation with Peptidoglycan induces interleukin 6 and TLR2 expression and a concomitant downregulation of expression of adiponectin receptors 1 and 2 in 3 T3-L1 adipocytes. Journal of inflammation (London, England). 2009, 6: 8-10.1186/1476-9255-6-8.CrossRefPubMedCentral
33.
Cheon IS, Woo SS, Kang SS, Im J, Yun CH, Chung DK, Park DK, Han SH: Peptidoglycan-mediated IL-8 expression in human alveolar type II epithelial cells requires lipid raft formation and MAPK activation. Molecular immunology. 2008, 45 (6): 1665-1673. 10.1016/j.molimm.2007.10.001.CrossRefPubMed
34.
Evander M, Frazer IH, Payne E, Qi YM, Hengst K, McMillan NA: Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol. 1997, 71 (3): 2449-2456.PubMedPubMedCentral
35.
Harada H, Nakagawa H, Oyama K, Takaoka M, Andl CD, Jacobmeier B, von Werder A, Enders GH, Opitz OG, Rustgi AK: Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation. Mol Cancer Res. 2003, 1 (10): 729-738.PubMed
36.
Veale R, Thornley AL: Increased Single Class Low-Affinity Egf Receptors Expressed by Human Esophageal Squamous Carcinoma Cell-Lines. S Afr Med J Sci. 1989, 85: 375-379.
37.
Pyeon D, Pearce SM, Lank SM, Ahlquist P, Lambert PF: Establishment of human papillomavirus infection requires cell cycle progression. PLoS pathogens. 2009, 5 (2): e1000318-10.1371/journal.ppat.1000318.CrossRefPubMedPubMedCentral
38.
Buck CB, Pastrana DV, Lowy DR, Schiller JT: Generation of HPV pseudovirions using transfection and their use in neutralization assays. Methods in molecular medicine. 2005, 119: 445-462.PubMed
39.
Buck CB, Pastrana DV, Lowy DR, Schiller JT: Efficient intracellular assembly of papillomaviral vectors. J Virol. 2004, 78 (2): 751-757. 10.1128/JVI.78.2.751-757.2004.CrossRefPubMedPubMedCentral
40.
Meerbach A, Gruhn B, Egerer R, Reischl U, Zintl F, Wutzler P: Semiquantitative PCR analysis of Epstein-Barr virus DNA in clinical samples of patients with EBV-associated diseases. Journal of medical virology. 2001, 65 (2): 348-357. 10.1002/jmv.2040.CrossRefPubMed
41.
Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods (San Diego, Calif. 2001, 25 (4): 402-408. 10.1006/meth.2001.1262.CrossRef
42.
Bergant Marusic M, Ozbun MA, Campos SK, Myers MP, Banks L: Human papillomavirus L2 facilitates viral escape from late endosomes via sorting nexin 17. Traffic (Copenhagen, Denmark). 2012, 13 (3): 455-467. 10.1111/j.1600-0854.2011.01320.x.CrossRef
43.
Drobni P, Mistry N, McMillan N, Evander M: Carboxy-fluorescein diacetate, succinimidyl ester labeled papillomavirus virus-like particles fluoresce after internalization and interact with heparan sulfate for binding and entry. Virology. 2003, 310 (1): 163-172. 10.1016/S0042-6822(03)00114-4.CrossRefPubMed
44.
Schäfer G, Guler R, Murray G, Brombacher F, Brown GD: The role of scavenger receptor B1 in infection with Mycobacterium tuberculosis in a murine model. PloS one. 2009, 4 (12): e8448-10.1371/journal.pone.0008448.CrossRefPubMedPubMedCentral
45.
Thompson MP, Kurzrock R: Epstein-Barr virus and cancer. Clin Cancer Res. 2004, 10 (3): 803-821. 10.1158/1078-0432.CCR-0670-3.CrossRefPubMed
46.
Birkenbach M, Tong X, Bradbury LE, Tedder TF, Kieff E: Characterization of an Epstein-Barr virus receptor on human epithelial cells. The Journal of experimental medicine. 1992, 176 (5): 1405-1414. 10.1084/jem.176.5.1405.CrossRefPubMed
47.
Icenogle J: Analysis of the Sequences of the L1 and L2 Capsid Proteins of Papillomaviruses. Centres for Disease Control, Atlanta, Georgia. 1995, III-74: III-90.
48.
McMillan NA, Payne E, Frazer IH, Evander M: Expression of the alpha6 integrin confers papillomavirus binding upon receptor-negative B-cells. Virology. 1999, 261 (2): 271-279. 10.1006/viro.1999.9825.CrossRefPubMed
49.
Yoon CS, Kim KD, Park SN: Cheong SW: alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP. Biochemical and biophysical research communications. 2001, 283 (3): 668-673. 10.1006/bbrc.2001.4838.CrossRefPubMed
50.
Selinka HC, Florin L, Patel HD, Freitag K, Schmidtke M, Makarov VA, Sapp M: Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus. J Virol. 2007, 81 (20): 10970-10980. 10.1128/JVI.00998-07.CrossRefPubMedPubMedCentral
51.
Um SJ, Kim EJ, Hwang ES, Kim SJ, Namkoong SE, Park JS: Antiproliferative effects of retinoic acid/interferon in cervical carcinoma cell lines: cooperative growth suppression of IRF-1 and p53. Int J Cancer. 2000, 85 (3): 416-423. 10.1002/(SICI)1097-0215(20000201)85:3<416::AID-IJC19>3.0.CO;2-3.CrossRefPubMed
52.
van Heerden WE, van Rensburg EJ, Engelbrecht S, Raubenheimer EJ: Prevalence of EBV in oral squamous cell carcinomas in young patients. Anticancer research. 1995, 15 (5B): 2335-2339.PubMed
53.
Van Rensburg EJ, Engelbrecht S, Van Heerden W, Raubenheimer E, Schoub BD: Detection of EBV DNA in oral squamous cell carcinomas in a black African population sample. In vivo (Athens, Greece). 1995, 9 (3): 199-202.
54.
Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G, Holm R, Johansson B, Hagmar B: Use of multiple PCR primer sets for optimal detection of human papillomavirus. Journal of clinical microbiology. 1996, 34 (9): 2095-2100.PubMedPubMedCentral
55.
Baay MF, Quint WG, Koudstaal J, Hollema H, Duk JM, Burger MP, Stolz E, Herbrink P: Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. Journal of clinical microbiology. 1996, 34 (3): 745-747.PubMedPubMedCentral
56.
Tornesello ML, Monaco R, Nappi O, Buonaguro L, Buonaguro FM: Detection of mucosal and cutaneous human papillomaviruses in oesophagitis, squamous cell carcinoma and adenocarcinoma of the oesophagus. J Clin Virol. 2009, 45 (1): 28-33. 10.1016/j.jcv.2009.02.004.CrossRefPubMed
57.
Chaiwongkot A, Pientong C, Ekalaksananan T, Kongyingyoes B, Thinkhamrop J, Yuenyao P, Sriamporn S: Evaluation of primers and PCR performance on HPV DNA screening in normal and low grade abnormal cervical cells. Asian Pac J Cancer Prev. 2007, 8 (2): 279-282.PubMed
58.
59.
Van Heyningen E: Medical practice in the Eastern Cape. Clio medica (Amsterdam, Netherlands). 2004, 74: 169-194.
60.
Bradshaw D, Nannan N, Groenewald P, Joubert J, Laubscher R, Nojilana B, Norman R, Pieterse D, Schneider M: Provincial mortality in South Africa, 2000–priority-setting for now and a benchmark for the future. South African medical journal =. Suid-Afrikaanse tydskrif vir geneeskunde. 2005, 95 (7): 496-503.PubMed
61.
Schneider M, Bradshaw D, Steyn K, Norman R, Laubscher R: Poverty and non-communicable diseases in South Africa. Scandinavian journal of public health. 2009, 37 (2): 176-186. 10.1177/1403494808100272.CrossRefPubMed
62.
Castellsague X, Diaz M, de Sanjose S, Munoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ: Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. Journal of the National Cancer Institute. 2006, 98 (5): 303-315. 10.1093/jnci/djj067.CrossRefPubMed
63.
Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E: Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005, 366 (9490): 991-998. 10.1016/S0140-6736(05)67069-9.CrossRefPubMed
64.
Bienkowska-Haba M, Patel HD, Sapp M: Target cell cyclophilins facilitate human papillomavirus type 16 infection. PLoS pathogens. 2009, 5 (7): e1000524-10.1371/journal.ppat.1000524.CrossRefPubMedPubMedCentral
65.
Horvath CA, Boulet GA, Renoux VM, Delvenne PO, Bogers JP: Mechanisms of cell entry by human papillomaviruses: an overview. Virol J. 2010, 7: 11-10.1186/1743-422X-7-11.CrossRefPubMedPubMedCentral
66.
Hourihan RN, O’Sullivan GC, Morgan JG: Transcriptional gene expression profiles of oesophageal adenocarcinoma and normal oesophageal tissues. Anticancer research. 2003, 23 (1A): 161-165.PubMed
67.
Yamakawa N, Kaneda K, Saito Y, Ichihara E, Morishita K: The increased expression of integrin alpha6 (ITGA6) enhances drug resistance in EVI1(high) leukemia. PloS one. 2012, 7 (1): e30706-10.1371/journal.pone.0030706.CrossRefPubMedPubMedCentral
68.
Xi LF, Koutsky LA, Castle PE, Edelstein ZR, Meyers C, Ho J, Schiffman M: Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load. Cancer Epidemiol Biomarkers Prev. 2009, 18 (12): 3490-3496. 10.1158/1055-9965.EPI-09-0763.CrossRefPubMedPubMedCentral
Metadata
Title
The role of inflammation in HPV infection of the Oesophagus
Authors
Georgia Schäfer
Siti Kabanda
Beverly van Rooyen
Martina Bergant Marušič
Lawrence Banks
M Iqbal Parker
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2013
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-13-185

Other articles of this Issue 1/2013

BMC Cancer 1/2013 Go to the issue

Research article

Polymorphism of A133S and promoter hypermethylation in Ras association domain family 1A gene (RASSF1A) is associated with risk of esophageal and gastric cardia cancers in Chinese population from high incidence area in northern China

Research article

Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer

Technical advance

Development of a novel cell-based assay system EPISSAY for screening epigenetic drugs and liposome formulated decitabine

Research article

Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine

Research article

Upregulation of CPE promotes cell proliferation and tumorigenicity in colorectal cancer

Research article

Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits